SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-21-041346
Filing Date
2021-02-12
Accepted
2021-02-12 15:45:53
Documents
2
Group Members
BALLAISON TRUST

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d130634dsc13ga.htm SC 13G/A 49652
2 EX-99.1 d130634dex991.htm EX-99.1 3429
  Complete submission text file 0001193125-21-041346.txt   54787
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Subject) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50211 | Film No.: 21626730
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 325 WATERFRONT DRIVE OMAR HODGE BUILDING SECOND FLOOR ROAD TOWN, TORTOLA D8 VG1110
Business Address 325 WATERFRONT DRIVE OMAR HODGE BUILDING SECOND FLOOR ROAD TOWN, TORTOLA D8 VG1110 41223124545
Castellina Ventures Ltd. (Filed by) CIK: 0001751785 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8
Type: SC 13G/A